Sterile and contained pharmaceutical product transfer specialist, ChargePoint Technology has been acquired by Arcline Investment Management. The deal will see ChargePoint Technology, headquartered in Liverpool, UK, become part of Arcline’s broader specialty process technologies platform offering, and enable it to strengthen its global presence, providing an enhanced, more localized service to its customers worldwide.
 
The transaction marks an exit for UK mid-market private equity firm LDC following a four-year partnership. Arcline is a growth-oriented private equity firm that seeks to invest in thriving businesses with structurally recurring revenue streams in high value industries. The firm’s primary sectors of interest include defense, aerospace, critical infrastructure services, industrial & biopharmaceutical technology, life sciences and specialty materials. Launched in 2019, Arcline currently has $4.3 billion in cumulative capital commitments. The firm’s more than 35 professionals are predominantly based in New York and San Francisco.
 

Working with Arcline, ChargePoint will be able to accelerate its product development pipeline, empowering the company to deliver enhanced sterile and contained process solutions, as well as new innovations and technology platforms, to market faster.
 
ChargePoint represents the leading investment into Arcline’s new process technology platform and is anticipated to be the first of several acquisitions to support this platform. ChargePoint will provide the platform with high-performance sterile and contained powder transfer equipment, such as its single-use powder transfer bags and split-butterfly valves (SBVs). These are industry leading solutions to support both high-potency active pharmaceutical ingredient (HPAPI) processing as well as stringent aseptic manufacturing required by pharmaceutical and bioprocessing applications, to establish safe and reliable manufacturing process environments.
 
The new investment will offer benefits for ChargePoint and its customers, allowing the business to increase and deepen its local presence in key European, American and Asian markets.